Functional inhibition of the HPG axis is demonstrated by the recovery of testosterone levels and by the improvement in signs and symptoms of testosterone deficiency (TD) in nearly half of hypogonadal patients with prolactin-secreting pituitary adenoma (PSPA) receiving effective treatments to reduce prolactin levels [5]. This evidence concerns the gene PRL and pituitary gland adenoma.